Author:
Li Xinsi,Li Qian,Wang Li,Ding Huifen,Wang Yizhong,Liu Yunfei,Gong Ting
Abstract
Atherosclerosis (AS) is a complex disease caused by multiple pathological factors threatening human health-the pathogenesis is yet to be fully elucidated. In recent years, studies have exhibited that the onset of AS is closely involved with oral and gut microbiota, which may initiate or worsen atherosclerotic processes through several mechanisms. As for how the two microbiomes affect AS, existing mechanisms include invading plaque, producing active metabolites, releasing lipopolysaccharide (LPS), and inducing elevated levels of inflammatory mediators. Considering the possible profound connection between oral and gut microbiota, the effect of the interaction between the two microbiomes on the initiation and progression of AS has been investigated. Findings are oral microbiota can lead to gut dysbiosis, and exacerbate intestinal inflammation. Nevertheless, relevant research is not commendably refined and a concrete review is needed. Hence, in this review, we summarize the most recent mechanisms of the oral microbiota and gut microbiota on AS, illustrate an overview of the current clinical and epidemiological evidence to support the bidirectional connection between the two microbiomes and AS.
Reference112 articles.
1. Human oral, gut, and plaque microbiota in patients with atherosclerosis;Koren;Proc Natl Acad Sci U S A,2011
2. Inflammation, atherosclerosis, and coronary artery disease;Hansson;N Engl J Med,2005
3. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study;Song;Lancet Glob Health,2020
4. Inflammasomes and atherosclerosis: a mixed picture;Tall;Circ Res,2023
5. Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond;Weber;Eur Heart J,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献